Product Categories
| Country: | China |
|---|---|
| Tel: | 16588669988 |
| Mobile: | 16588669988 |
| E-mail: | ryan.shao@pipharma.com.cn |
| QQ: | |
| Skype: | Chat Now! |
| Address: | No.20 Building, Area A ,Park Street South, Industry & Trade Road West Industrial Park, Shuangtaizi District |
|
Liaoning Pharmaceutical Innovation Co., Ltd registered on September 16th, 2021, with a registered capital of 12 million RMB, is located in Chemical Industrial District, Panjin, Liaoning. It is a company engaged in the research, development, and production of active pharmaceutical ingredients and intermediates.
The company is a subsidiary of Tianjin Pharmaceutical Innovation Co., Ltd. Tianjin P&I was established in July 2009 and is located in the Tianjin Binhai Development District. It is a high-tech enterprise specializing in the research, development, and production of active pharmaceutical ingredients and intermediates and providing pharmaceutical research and development outsourcing services.
The company has a research and development center, a pilot workshop, and a GMP production base. It integrates research, pilot testing, and production, dedicated to providing high-quality pharmaceutical chemicals and contract manufacturing services to pharmaceutical companies worldwide. As a research-oriented and customer-centrist enterprise, it consistently strives to improve its technical innovation system. It prioritizes scientific and technological innovation, utilizes advanced and comprehensive production facilities, and has a robust quality assurance system to ensure the safe production of high-quality products. The company's progressive and innovative mindset, dedicated employees, and reasonable resource allocation are the solid foundation for the continuous development and growth of P&I.
The company's main business covers various regions around the world. P&I has 47 patents, including six invention patents, all of which have been granted. Tianjin P&I is recognized as a national high-tech enterprise. After more than a decade of development, it has established a production system spanning small-scale research and development to pilot and industrial-scale mass production. It has also found improved process technology research for active pharmaceutical ingredients,
|
|
| Product Name | MF | CAS | Details |
|---|
| Sarolaner | C23H18Cl2F4N2O5S | 1398609-39-6 | Details |
| Lotilaner | C20H14Cl3F6N3O3S | 1369852-71-0 | Details |
| semaglutide | C187H291N45O59 | 910463-68-2 | Details |
| Tirzepatide | 2023788-19-2 | Details |
| Retatrutide | 2381089-83-2 | Details |
| Liraglutide | C172H265N43O51 | 204656-20-2 | Details |
| Omeprazole | C17H19N3O3S | 73590-58-6 | Details |
| DMSO | C2H6OS | 67-68-5 | Details |
| Hydrocortisone Acetate | C23H32O6 | 50-03-3 | Details |
| Prednisolone-21-acetate | C23H30O6 | 52-21-1 | Details |
| Androstenedione | C19H26O2 | 63-05-8 | Details |
| Betamethasone | C22H29FO5 | 378-44-9 | Details |
| Algestone acetophenide | C29H36O4 | 24356-94-3 | Details |
| Budesonide | C25H34O6 | 51333-22-3 | Details |
| Tildipirosin | C41H71N3O8 | 328898-40-4 | Details |
| Flunixin Meglumine | C14H11F3N2O2.C7H17NO5 | 42461-84-7 | Details |
| Carbasalate calcium | C10H14CaN2O5 | 5749-67-7 | Details |
| Sulfamonomethoxine sodium | C12H15N4NaO4S | 1037-50-9 | Details |
| Imidocarb dipropionate | C22H26N6O3 | 55750-06-6 | Details |
| Cefquinome Sulphate | C23H26N6O9S3 | 118443-89-3 | Details |
| Rivaroxaban intermediate | C19H18ClN3O5S | 366789-02-8 | Details |
| Methoxatin | C14H6N2O8 | 72909-34-3 | Details |
| Intermediate of Rivaroxaban 2 | C14H17N3O4.ClH | 898543-06-1 | Details |
| Intermediate of Rivaroxaban 3 | C22H19N3O6 | 446292-08-6 | Details |
| Intermediate of Rivaroxaban 4 | C21H21N3O5 | 446292-07-5 | Details |
| Zuranolone | C25H35N3O2 | 1632051-40-1 | Details |
| Pentafluoropentanol | C5H7F5O | 148043-73-6 | Details |
| Sulfasalazine | C18H14N4O5S | 599-79-1 | Details |
| Sulfadimethoxine | C12H14N4O4S | 122-11-2 | Details |
| Meropenem | C17H25N3O5S | 96036-03-2 | Details |
| Carbamazepine | C15H12N2O | 298-46-4 | Details |
| Oxcarbazepine | C15H12N2O2 | 28721-07-5 | Details |
| Lacosamide | C13H18N2O3 | 175481-36-4 | Details |
| Rasagiline Mesylate | C13H17NO3S | 161735-79-1 | Details |
| Gliclazide | C15H21N3O3S | 21187-98-4 | Details |
| Sitagliptin Hydrochloride | C16H15F6N5O | 486460-32-6 | Details |
| Sitagliptin Phosphate | C16H15F6N5O.H3PO4 | 654671-78-0 | Details |
| Bezafibrate | C19H20ClNO4 | 41859-67-0 | Details |
| Dexketoprofen Trometamol | C20H25NO6 | 156604-79-4 | Details |
| Ketoprofen Lysinate | C22H28N2O5 | 57469-78-0 | Details |
| Imatinib Mesylate | C30H35N7O4S | 220127-57-1 | Details |
| Axitinib | C22H18N4OS | 319460-85-0 | Details |
| Gefitinib | C22H24ClFN4O3 | 184475-35-2 | Details |
| Erlotinib Hydrochloride | C22H24ClN3O4 | 183319-69-9 | Details |
| Acyclovir | C8H11N5O3 | 59277-89-3 | Details |
| Venlafaxine Hydrochloride | C17H28ClNO2 | 99300-78-4 | Details |
| Cilostazol | C20H27N5O2 | 73963-72-1 | Details |
| Atenolol | C14H22N2O3 | 29122-68-7 | Details |
| Tenofovir Disoproxil Succinate | C23H34N5O14P | 202138-50-9 | Details |
| Sildenafil Citrate | C28H38N6O11S | 171599-83-0 | Details |
| Meloxicam | C14H13N3O4S2 | 71125-38-7 | Details |
| Product Total： Product Page： | ||||
| 1 2 | ||||